Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufact
Recalled April 15, 2026 · FDA recall D-0474-2026 · Teva Pharmaceuticals USA
Hazard
CGMP Deviations: use of an unapproved raw material · FDA Class II
Units
113,943 Cartons
Sold at
Within U.S
Description
CGMP Deviations: use of an unapproved raw material
Product
Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch
Manufacturer(s)
Teva Pharmaceuticals USA, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →